Status:

ENROLLING_BY_INVITATION

Improved Diagnostics in Food Allergy Study

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

Royal College of Surgeons, Ireland

University of Manchester

Conditions:

Food Allergy

Eligibility:

All Genders

2-18 years

Phase:

NA

Brief Summary

The investigators will conduct low-dose intranasal allergen challenges on children and young people with an indeterminate diagnosis of food allergy to cow's milk or peanut. Blood samples will also be ...

Eligibility Criteria

Inclusion

  • IgE-sensitisation to peanut, (hen's) egg or cow's milk, with indeterminate clinical (allergy) status, defined as IgE-sensitisation below 95% positive predictive value (PPV) for diagnosis for either allergen-specific IgE or SPT, using published cut-offs OR clinician suspicion of tolerance (on basis of clinical history) despite IgE sensitisation \>95% PPV cut-offs.
  • Written informed consent from parent/guardian, with assent from children aged 6 years and above wherever possible. Participants aged over 16 years will need to provide their own informed consent.

Exclusion

  • Acute illness or current unstable asthma, defined as:
  • Febrile ≥38.0oC in last 72 hours
  • Acute wheeze in last 72 hours requiring treatment
  • Recent admission to hospital in preceding 2 weeks for acute asthma
  • Current medication
  • Asthma reliever medication required in preceding 72 hours
  • Recent administration of a medicine containing antihistamine within the last 3 days
  • Current oral steroid for asthma exacerbation or course completed within last 2 weeks
  • Unwilling or unable to fulfil study requirements

Key Trial Info

Start Date :

October 18 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2025

Estimated Enrollment :

166 Patients enrolled

Trial Details

Trial ID

NCT06097572

Start Date

October 18 2023

End Date

July 31 2025

Last Update

March 28 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Prof Jonathan Hourihane

Dublin, Ireland

2

Imperial College Healthcare NHS Trust (St. Mary's Hospital)

London, United Kingdom